Crispr Therapeutics shares owned by Commonwealth Equity Services
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Commonwealth Equity Services
from 13F filings
Historical chart of Commonwealth Equity Services investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Commonwealth Equity Services consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Commonwealth Equity Services
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $3.1M | 66k | 46.98 |
| 2024-06-30 | $3.3M | 62k | 54.01 |
| 2024-03-31 | $3.7M | 54k | 68.17 |
| 2023-12-31 | $2.9M | 47k | 62.60 |
| 2023-09-30 | $1.8M | 40k | 45.40 |
| 2023-06-30 | $2.3M | 41k | 56.14 |
| 2023-03-31 | $1.8M | 40k | 45.21 |
| 2022-12-31 | $2.1M | 51k | 40.64 |
| 2022-09-30 | $7.0M | 107k | 65.34 |
| 2022-06-30 | $2.8M | 47k | 60.76 |
| 2022-03-31 | $2.7M | 43k | 62.76 |
| 2021-12-31 | $2.7M | 35k | 75.77 |
| 2021-09-30 | $4.3M | 38k | 111.92 |
| 2021-06-30 | $5.7M | 35k | 161.87 |
| 2021-03-31 | $3.7M | 30k | 121.83 |
| 2020-12-31 | $4.3M | 28k | 153.10 |
| 2020-09-30 | $2.1M | 25k | 83.62 |
| 2020-06-30 | $1.8M | 25k | 73.47 |
| 2020-03-31 | $1.9M | 44k | 42.39 |
| 2019-12-31 | $1.9M | 31k | 60.89 |
| 2019-09-30 | $746k | 18k | 40.99 |
| 2019-06-30 | $839k | 18k | 47.10 |
| 2019-03-31 | $601k | 17k | 35.71 |
| 2018-12-31 | $364k | 13k | 28.57 |
| 2018-09-30 | $590k | 13k | 44.30 |
| 2018-06-30 | $727k | 12k | 58.76 |
| 2018-03-31 | $263k | 5.8k | 45.56 |
More positions owned by Commonwealth Equity Services
View all positions for Commonwealth Equity Services